Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
drug delivery
Biotech
Novartis inks $3.2B subcutaneous delivery deal with Alteogen
Novartis joins Biogen and GSK on the list of drugmakers to pay to access Alteogen's technology this year.
Nick Paul Taylor
Sep 2, 2026 7:51am
Novo Nordisk inks $2.1B oral drug delivery pact
Feb 25, 2026 8:00am
Merck teams up with British medtech Calla Lily
Feb 10, 2026 9:40am
Gilead garners lipid package for cancer asset in $300M pact
Jan 6, 2026 7:00am
Moderna's $500M pact with Nanexa to improve injectables delivery
Dec 11, 2025 7:35am
Enable Injections, Incyte ink drug delivery collab
Oct 29, 2025 10:15am